--- title: "RBC Capital Remains a Sell on Nordex (NRDXF)" type: "News" locale: "en" url: "https://longbridge.com/en/news/285204036.md" description: "RBC Capital analyst Colin Moody maintained a Sell rating on Nordex today and set a price target of €38.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Moody is a 4-star analyst with an average return of 14.0% and a 62.86% success rate. Currently, the analyst consensus on Nordex is a Moderate Buy with an average price target of €43.50." datetime: "2026-05-05T12:07:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285204036.md) - [en](https://longbridge.com/en/news/285204036.md) - [zh-HK](https://longbridge.com/zh-HK/news/285204036.md) --- # RBC Capital Remains a Sell on Nordex (NRDXF) RBC Capital analyst Colin Moody maintained a Sell rating on Nordex today and set a price target of €38.00. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Moody is a 4-star analyst with an average return of 14.0% and a 62.86% success rate. Currently, the analyst consensus on Nordex is a Moderate Buy with an average price target of €43.50. ### Related Stocks - [NDX1.DE](https://longbridge.com/en/quote/NDX1.DE.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) ## Related News & Research - [Goldman Sachs Keeps Their Buy Rating on Nordex (NRDXF)](https://longbridge.com/en/news/284170437.md) - [Nordex gets order for 70 MW wind power project Jasikovo in Serbia](https://longbridge.com/en/news/280652592.md) - [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md) - [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md) - [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)